James William Rogers Sells 23,030 Shares of Tempus AI, Inc. (NASDAQ:TEM) Stock

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) CFO James William Rogers sold 23,030 shares of the company's stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $45.97, for a total value of $1,058,689.10. Following the sale, the chief financial officer now owns 164,750 shares in the company, valued at approximately $7,573,557.50. This represents a 12.26 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

James William Rogers also recently made the following trade(s):

• On Tuesday, February 18th, James William Rogers sold 31,780 shares of Tempus AI stock. The stock was sold at an average price of $82.33, for a total value of $2,616,447.40.
• On Wednesday, February 5th, James William Rogers sold 8,712 shares of Tempus AI stock. The shares were sold at an average price of $67.57, for a total value of $588,669.84.

Tempus AI Price Performance

Shares of NASDAQ TEM traded up $3.31 during mid-day trading on Friday, reaching $51.35. The company had a trading volume of 9,890,627 shares, compared to its average volume of 5,060,523. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. Tempus AI, Inc. has a one year low of $22.89 and a one year high of $91.45. The business's 50-day simple moving average is $56.35 and its 200 day simple moving average is $51.40.

Remove Ads

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on TEM shares. William Blair reaffirmed a "market perform" rating on shares of Tempus AI in a report on Tuesday, February 25th. Guggenheim reaffirmed a "buy" rating on shares of Tempus AI in a report on Tuesday, February 25th. TD Cowen reaffirmed a "buy" rating and set a $74.00 price target (up previously from $58.00) on shares of Tempus AI in a report on Wednesday, February 5th. Needham & Company LLC raised their price target on Tempus AI from $56.00 to $70.00 and gave the company a "buy" rating in a report on Tuesday, February 25th. Finally, Loop Capital cut their price target on Tempus AI from $57.00 to $52.00 and set a "buy" rating for the company in a report on Tuesday, January 14th. Six research analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $61.18.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. First Horizon Advisors Inc. bought a new position in Tempus AI in the third quarter valued at about $30,000. Operose Advisors LLC bought a new position in Tempus AI in the fourth quarter valued at about $25,000. Farther Finance Advisors LLC bought a new position in Tempus AI in the fourth quarter valued at about $34,000. Prestige Wealth Management Group LLC grew its holdings in shares of Tempus AI by 910.4% during the fourth quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company's stock worth $36,000 after purchasing an additional 965 shares during the last quarter. Finally, NewEdge Advisors LLC bought a new stake in shares of Tempus AI during the fourth quarter worth about $49,000. Institutional investors own 24.22% of the company's stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.